Involvement of Bacterial Extracellular Membrane Nanovesicles in Infectious Diseases and Their Application in Medicine

Konstantin A Lusta1, Anastasia V Poznyak1, Larisa Litvinova2

  • 1Institute for Atherosclerosis Research, Osennyaya Street 4-1-207, 121609 Moscow, Russia.

Pharmaceutics
|December 23, 2022
PubMed

Insights

Bacterial extracellular membrane nanovesicles (EMNs) are key in disease development and immune response. These nanovesicles show promise as vaccine carriers and therapeutic agents for infections and cancer.

Area of Science:

  • Microbiology
  • Immunology
  • Nanotechnology

Background:

  • Bacterial extracellular membrane nanovesicles (EMNs) are increasingly recognized for their roles in disease pathogenesis.
  • EMNs are implicated in infectious diseases caused by Gram-positive and Gram-negative bacteria, as well as in cancer development.

Purpose of the Study:

  • To review the diverse roles of EMNs in various pathologies.
  • To explore the therapeutic and preventive potential of EMNs.

Main Methods:

  • Literature review focusing on EMNs in disease and therapy.
  • Analysis of EMNs' involvement in pathogenesis and immune stimulation.

Main Results:

  • EMNs play a significant role in the pathogenesis of numerous infectious diseases and cancers.
  • EMNs are effective carriers for vaccines against infectious diseases.
  • EMNs stimulate immune responses against bacterial pathogens and tumor cells.

Conclusions:

  • EMNs are crucial in understanding disease mechanisms and host-pathogen interactions.
  • EMNs offer significant potential for therapeutic applications, including vaccine development and treatment strategies for infections and cancer.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
151
Intracellular Movement of Viruses and Bacteria01:10

Intracellular Movement of Viruses and Bacteria

Intracellular bacteria and viruses often comprise a group of highly infectious pathogens that can cause several diseases. Bacterial pathogens include those belonging to the genus Rickettsia responsible for conditions such as rocky mountain spotted fever and the Mediterranean spotted fever; Chlamydia, a genus responsible for a sexually transmitted disease; Coxiella burnetii, an agent responsible for Q fever. Viral pathogens include vaccinia—a poxvirus, and herpes simplex virus—a...
2.9K
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.6K